BLU-701

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameBLU-701
Drug Alias NameBLU-701BLU 701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR 19del inhibitorsEGFR L858R inhibitorsEGFR C797S inhibitors +[4] 
TargetsEpidermal growth factor receptor erbB1EGFR 19delEGFR L858R +[4] 
Therapy Area/IndicationsLung DiseasesRespiratory Tract DiseasesCarcinoma, Non-Small-Cell Lung +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBlueprint Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab (Shanghai) Co LtdBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsLung DiseasesRespiratory Tract DiseasesCarcinoma, Bronchogenic +[11] 

Other Information

ATC CodeN/A
Related LinksN/A